Status:
COMPLETED
The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment
Lead Sponsor:
University Ghent
Collaborating Sponsors:
Care of Sweden AB
Conditions:
Pressure Ulcer
Pressure Injury
Eligibility:
All Genders
65-110 years
Phase:
NA
Brief Summary
Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare s...
Eligibility Criteria
Inclusion
- At risk of pressure ulcer development based on a Braden score ≤ 17 or pressure ulcer category III or IV
- Bedbound or chair bound
- Aged ≥ 65
Exclusion
- Short-stay residents (expected length of stay ≤14 days)
- End of life care
- Medical contraindication for patient repositioning/turning
Key Trial Info
Start Date :
February 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04890678
Start Date
February 20 2019
End Date
October 30 2019
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WZC Hof ter Waarbeek
Asse, Vlaams-Brabant, Belgium, 1770